Brief: Ocugen Intends To Restate Financial Statements For The Year Ended December 31, 2022 And For Each Of The First Three Quarters Of 2022 And 2023

Ocugen

01/04/2024 23:25

April 1 (Reuters) - Ocugen Inc  OCGN.O :
    * OCUGEN INC -  INTENDS TO RESTATE FINANCIAL STATEMENTS FOR
THE
YEAR ENDED DECEMBER 31, 2022 AND FOR EACH OF THE FIRST THREE
QUARTERS OF 2022 AND 2023
    * OCUGEN INC -  REQUIRES ADDITIONAL TIME TO PREPARE AND
REVIEW ITS
FINANCIAL STATEMENTS AND OTHER DISCLOSURES IN ITS 2023 FORM 10-K
    * OCUGEN - IDENTIFIED MATERIAL WEAKNESS IN INTERNAL CONTROL
OVER
FINANCIAL REPORTING AND, AS RESULT, INEFFECTIVE DISCLOSURE
CONTROLS AND PROCEDURES

Source text for Eikon:  ID:n0001104659-24-041941 
Further company coverage:  OCGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))